Site WA-503 — Emerald City Clinical Trials
Seattle, WA · West · PI Dr. Hugo Bergman · Coordinator Amara Diallo
ActiveLow0
Activation Readiness
IRB / Ethics approvalApproved
Regulatory documents10/10 complete
Investigator trainingComplete
Staff trainingComplete
ContractApproved
BudgetApproved
Planned activationActivated 2026-04-22
Enrollment
17of 25 patients (68%)
Enrollment rate3.6 patients / month
StatusActive
Operations
Data entryCurrent
Open data queries3
Protocol deviations0
Outstanding tasks1
Last site activity2 days ago
Last monitoring visit26 days ago
Agent Assessment
LowRisk score
0/100
Why am I seeing this?
WA-503 shows no readiness or performance exceptions across regulatory, training, enrollment, and data quality checks.
Primary risk factors
- No exceptions detected against study thresholds.
Recommended action
No action required — WA-503 is operating within study expectations.
Agent actions for this site
No actions prepared yet for WA-503 in trial CT-2026-301.